CERo Therapeutics Quote - CERO

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.20

Bid

0.199

Offer

0.20

Volume

4,545,711

0.198 Day's Range 0.237

0.165 52 Week Range 12.38

Previous Close

0.2429

Open

0.227

Last Trade

500

0.2

(formt)

Last Trade Time

06:58:20

Average Volume (3m)

2,916,749

Financial Volume

US$ 958,334

VWAP

0.210822

CERo Therapeutics, Inc. Presents CER-1236 Data Supporting Use in AML at Global Cell & Gene Therapy Summit 2024

Company anticipates initial human trials to focus on AML upon IND clearance SOUTH SAN FRANCISCO, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO...

CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236

Company anticipates near term filing of Investigational New Drug Application to FDA SOUTH SAN FRANCISCO, Calif., June 13, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq:...

CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236

Company continuing IND-enabling activities in preparation for submission of Investigational New Drug Application to FDA SOUTH SAN FRANCISCO, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- CERo...

CERo Therapeutics, Inc. Provides Corporate Update for Shareholders

SOUTH SAN FRANCISCO, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq:CERO) (“CERo”) an innovative immunotherapy company seeking to advance the next generation...

CERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing Attributes

SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) (“CERo”) an innovative immunotherapy company seeking to advance the next...

CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients

CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) ("CERo") an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic...

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0045	2.30179028133	0.1955	0.2689	0.18	8896902	0.22432354	CS
4	-0.1181	-37.1266897202	0.3181	0.367608	0.165	6751263	0.22544407	CS
12	-1.22	-85.9154929577	1.42	1.71	0.165	2916749	0.27891308	CS
26	-5.05	-96.1904761905	5.25	12.38	0.165	2197285	1.10254152	CS
52	-5.05	-96.1904761905	5.25	12.38	0.165	2197285	1.10254152	CS
156	-5.05	-96.1904761905	5.25	12.38	0.165	2197285	1.10254152	CS
260	-5.05	-96.1904761905	5.25	12.38	0.165	2197285	1.10254152	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CSXCleanSpace Holdings Limited	AUD 0.59 (96.67%)	288.09k
AUKAumake Limited	AUD 0.005 (66.67%)	17.91M
MMMMarley Spoon SE	AUD 0.028 (55.56%)	272.33k
MTLMantle Minerals Limited	AUD 0.003 (50.00%)	1.09M
MCTMetalicity Ltd	AUD 0.003 (50.00%)	114.59k
LDROLode Resources Ltd	AUD 0.001 (-75.00%)	300.7k
NTMNT Minerals Ltd	AUD 0.006 (-50.00%)	5.91M
PKOPeako Limited	AUD 0.004 (-42.86%)	750.69k
ADGOAAdelong Gold Ltd	AUD 0.002 (-33.33%)	11.75M
BOAOBoadicea Recources Ltd	AUD 0.002 (-33.33%)	481.52k
ZIPZip Co Limited	AUD 1.6925 (-3.84%)	75.81M
NGSNutritional Growth Solutions Ltd	AUD 0.003 (0.00%)	44.28M
FG1Flynn Gold Limited	AUD 0.033 (32.00%)	43.3M
CLECyclone Metals Limited	AUD 0.001 (0.00%)	39.95M
PLSPilbara Minerals Limited	AUD 2.975 (-0.17%)	35.36M